See RealTime in action.

See how RealTime can simplify your clinical research operations.

Get a personalized demo tailored to your organization, workflows, and goals, with a closer look at the solutions most relevant to your team.

Request a Live Demo

Real Users. Real Results.

In clinical trials, the product of what we do is documentation. The data is the product. RealTime enables us to create a better product because we’re able to create high-quality data for all of our studies.

Jeffrey Smyth

President & Executive Director,
TrueBlue Clinical Research

After trying out RealTime for six months, the company decided there’s no way we are going back to paper no matter what happens.

Mazhar Jaffry

CEO, Revival Research Institute

RealTime-eSource definitely reduces the number of errors in visits, making it virtually foolproof for coordinators to avoid errors. With eSource, the protocol has already been clearly translated electronically. The details and order of execution are already built out in the eSource template. And alerts and notifications within the system make it impossible for our coordinators to miss anything.

Jessica Baird

Operations Manager, University of the Sunshine Coast

Being able to prequalify patients has allowed us to shorten our funnel window. With the web app, our timeline has dropped down to 4-6 hours.

MJ Hammersma

VP of Operations, Cedar Health Research

If you ever question if you’ve made the right decision moving forward with an eRegulatory system, just take a look at the reduction in hours and how satisfied the staff is because their work is now so much easier.

Julia Brenner

Finance and Regulatory Manager, Coastal Pediatric Research

As Helios continues to grow, our Devana-based processes will make it easier and faster to get new sites onboarded and up to speed – accelerating business growth and bringing new treatment options to more patients across the country.

EB McLindon

Co-Founder and CEO, Helios Clinical Research

Access the Report

Complete the form below to access the full report.